RETHINC: REdefining THerapy In Early COPD for the Pulmonary Trials Cooperative

NCT02867761 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

780

Enrollment

OTHER

Sponsor class

Conditions

COPD (Chronic Obstructive Pulmonary Disease)

Interventions

DRUG: Indacaterol/Glycopyrrolate
DRUG: Placebo

Sponsor

University of Michigan

Collaborators

[object Object]